Express Pharma
Home  »  Latest Updates  »  Hester Biosciences launches PPR and goat pox vaccine

Hester Biosciences launches PPR and goat pox vaccine

5

Is the first company in India to manufacture the goat pox vaccine

Hester Biosciences has launched its PPR (Peste Des Petits Ruminants) vaccine and goat pox vaccine. PPR vaccine is to be given annually to sheep and goats. PPR disease causes dysentery and death of the animal and is therefore a disease of high economical importance worldwide. The total targeted population of sheep and goat for PPR vaccine in the world is 145 crores. In India, the targeted population is 20 crores.

Rajiv Gandhi, Chief Executive Officer and Managing Director, Hester Biosciences said, “The world market for PPR vaccine is slated to be for Rs 300 crores annually. The Indian market is slated to be Rs 40 crores annually. The PPR vaccine will contribute toward also the disease eradication programmes of the Government of India. Hester is also the first company in India to manufacture the goat pox vaccine. This vaccine is to be given annually to goats. Goat pox disease causes death in goats.”

Apart from poultry and large animal vaccines, the company has recently forayed into poultry health products and large animal health products. These four verticals put together will underpin Hester’s identity as a strong animal health company, addressing all segments in the animal health care sector. Company currently manufactures and markets veterinary vaccines and health products for India and global markets. Company’s product portfolio comprises of over 47 vaccines and over 35 health products.

Gandhi added, “We have already invested Rs 7 crores in plant and machinery for stepping up our vaccine production capacity as well as towards increasing our vaccine range. We hope to invest another Rs 18 crores in the next couple of years. This expansion will help us to meet rising demand from domestic and export markets.”

EP News BureauMumbai

Comments are closed.